Paid Clinical Trials in Chattanooga, TN
As of July 2026, 132 paid clinical trials are recruiting in Chattanooga, Tennessee. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Chattanooga offers studies at sites including GSK Investigational Site for conditions such as Carcinoma, Non-Small-Cell Lung, Generalized Myasthenia Gravis, AChR-Ab Seropositive Generalized Myasthenia Gravis, Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Chattanooga
Trials by drug in Chattanooga
Filter results
Newly added in Chattanooga
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
121 clinical trials
Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)
PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
SELUTION 4 De Novo Small Vessel IDE Trial
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
Top Research Study Locations in Chattanooga
Researchers run research studies in Chattanooga, TN at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease, Irritable Bowel Syndrome, Multiple Myeloma | 5 |
| Southeast Renal Research Institute | Diabetic Kidney Disease (DKD), End Stage Kidney Disease, Focal Segmental Glomerulosclerosis | 5 |
| Erlanger Health System | AChR-Ab Seropositive Generalized Myasthenia Gravis, gMG, Generalized Myasthenia Gravis | 5 |
| T C Thompson Children's Hospital | Adrenal Gland Pheochromocytoma, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma | 4 |
| Tennessee Oncology, PLLC - Chattanooga Downtown | Advanced Non-Small Cell Lung Cancer, Advanced/Metastatic Urothelial Cancer, Cancer of the Prostate | 4 |
| Tennessee Oncology, PLLC - Chattanooga Med Park II | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 4 |
| Tennessee Oncology, PLLC - Chattanooga Memorial | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 4 |
| ClinSearch, LLC | Chronic Obstructive Pulmonary Disease, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis | 3 |
| Erlanger Health, Inc. | Cardiovascular Disease, Endometrioid Ovarian Cancer, Fallopian Tube Cancer | 3 |
| Tennessee Oncology | Advanced Solid Tumors, B-Cell Non-Hodgkins Lymphoma, Colorectal Cancer (CRC) | 3 |
| Tennessee Oncology - Chattanooga | Carcinoma, Non-Small-Cell Lung, Melanoma, Metastatic Castration-resistant Prostate Neoplasms | 3 |
| Tennessee Oncology Chattanooga | Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Neoplasm Metastasis | 3 |
| Tennessee Oncology, PLLC - Investigational Drug Services/Supply Storage | Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, Advanced/Metastatic Urothelial Cancer | 3 |
| Vascular Institute of Chattanooga | Arteriovenous Fistula, Chronic Total Occlusion of Artery of the Extremities, End-stage Renal Disease | 3 |
| Clinical Trial Site | Generalized Myasthenia Gravis, High Cardiovascular Risk, High Risk Cardiovascular Disease | 2 |
| Erlanger Health | Epithelial Ovarian Cancer, Fallopian Tube Cancer, Heart Failure | 2 |
| Erlanger Neuroscience Institute | AChR-Ab Seropositive Generalized Myasthenia Gravis, Generalized Myasthenia Gravis, Generalized Myasthenia Gravis (gMG) | 2 |
| Galen Medical Group - Galen Hepatology | Hepatitis, Metabolic Dysfunction-Associated Steatotic Liver Disease | 2 |
| Tennessee Oncology PLLC | Prostate Cancer, Cancer of the Prostate, Hormone Sensitive Prostate Cancer | 2 |
| Tennessee Oncology, PLLC | Acinar Cell Carcinoma, Advanced Cancer, Breast Cancer | 2 |
| Tennessee Oncology, PLLC - Chattanooga East | Advanced/Metastatic Urothelial Cancer, Cancer of the Prostate, Hormone Sensitive Prostate Cancer | 2 |
| University Diabetes & Endocrine Consultants | T1D, T1DM, T1DM - Type 1 Diabetes Mellitus | 2 |
| WR-ClinSearch, LLC | Acute Migraine, Migraine | 2 |
| WR-Clinsearch, LLC | Atherosclerotic Cardiovascular Disease (ASCVD), COVID-19 SARS-CoV-2 Infection, Elevated Lp(a) | 2 |
| Woolfson Eye Institute | Forme Fruste Keratoconus (FFK), Keratoconus, Down Syndrome (DS) | 2 |
Active & Upcoming Studies in Chattanooga (2026)
Recruiting trials in Chattanooga grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (44 active studies)
- Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer · Phase 1, Phase 2 · Pfizer
- Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer · Phase 1, Phase 2 · Pfizer
Diabetes & metabolic (11 active studies)
Neurology & pain (9 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Cardiovascular (9 active studies)
Vaccines (2 active studies)
Pediatric (1 active study)
- CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D) · Phase 1, Phase 2 · COUR Pharmaceutical Development Company, Inc.
Common conditions studied in Chattanooga
- Carcinoma, Non-Small-Cell Lung (5 active studies)
- Generalized Myasthenia Gravis (4 active studies)
- AChR-Ab Seropositive Generalized Myasthenia Gravis (3 active studies)
- Breast Cancer (3 active studies)
- Chronic Lymphocytic Leukemia (3 active studies)
- Fallopian Tube Cancer (3 active studies)
Leading research sponsors in Chattanooga
- AstraZeneca
- Pfizer
- GlaxoSmithKline
- Boehringer Ingelheim
- Children's Oncology Group
Frequently asked questions
How many paid clinical trials are currently recruiting in Chattanooga?
There are approximately 132 recruiting clinical trials in Chattanooga, Tennessee listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Chattanooga pay participants?
Most recruiting trials in Chattanooga compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Chattanooga?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Chattanooga?
The most common conditions under active study in Chattanooga include Carcinoma, Non-Small-Cell Lung (5), Generalized Myasthenia Gravis (4), AChR-Ab Seropositive Generalized Myasthenia Gravis (3), Breast Cancer (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Chattanooga?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Chattanooga on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Chattanooga?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Chattanooga?
Recruiting research sites in Chattanooga include GSK Investigational Site, Southeast Renal Research Institute, Erlanger Health System, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Chattanooga right now?
The largest active categories in Chattanooga are Cancer & tumors (44), Diabetes & metabolic (11), Neurology & pain (9). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.